Mercer Global Advisors
UPB

Mercer Global Advisors’s Upstream Bio Inc UPB Stock Holding History

Mercer Global Advisors’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.4K Buy
+13,352
New +$112K ﹤0.01% 3895

Other funds holding UPB

Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's UPB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 13,352 shares worth $92.4K. The stake represents ﹤0.01% of the portfolio and ranks #3895 among its holdings.

135 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Mercer Global Advisors held 13,352 shares of Upstream Bio Inc worth $92.4K as of Q2 2026.
  • Upstream Bio Inc was a new Mercer Global Advisors position in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3895 holding.
  • 135 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.